围产期HIV感染青少年长期治疗下的神经认知发展:与健康匹配对照的纵向研究
该纵向研究对21名接受联合抗逆转录病毒治疗的围产期HIV感染青少年和23名健康匹配对照重复认知测试(平均间隔4.6年)。HIV感染组IQ评分随时间增加显著更多,但执行功能下降显著更多,其他认知域轨迹无统计学差异,认知损害患病率两组相似。
要点
- HIV感染青少年IQ评分增加显著多于对照,但执行功能下降显著更多。
- 执行功能偏离可能与更晚启动cART或早期脑损伤有关。
- 整体认知发展与健康同龄人相似,认知损害患病率无差异。
核心结论
- 接受cART治疗的围产期HIV感染青少年整体认知发展与健康同龄人相似。
- 执行功能轨迹出现偏离,可能由早期脑损伤解释。
研究设计与样本
- 纵向研究,重复标准化认知测试平均间隔4.6年(标准差0.3)。
- 纳入21名PHIV+和23名HIV-参与者,两组年龄、性别、种族和社会经济地位相似。
主要发现
- 处理速度、工作记忆、学习能力和视觉运动功能轨迹两组无统计学差异。
- MNC评估的认知损害患病率两组在两个时间点均相似。
临床怎么用
- 对长期cART治疗的围产期HIV感染青少年应关注执行功能变化。
- 较晚启动cART者可能需更密切的神经认知监测。
局限性
- 样本量较小(21例PHIV+和23例HIV-)。
- 随访间隔平均4.6年,可能不足以捕捉长期轨迹。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A cross-sectional analysis of the Neurological, cOgnitive and VIsual performance in hiv-infected Children cohort showed significant cognitive impairment in combination antiretroviral therapy (cART)-treated, perinatally human immunodeficiency virus (HIV)-infected adolescents (PHIV+) compared to age-, sex-, ethnicity- and socioeconomic status (SES)-matched HIV-negative controls (HIV-). In this longitudinal study, we compared cognitive development in the same adolescents over time. METHODS: We repeated the standardized cognitive test battery after a mean of 4.6 years (standard deviation 0.3). In participants who completed both assessments, we compared cognitive trajectories between groups in the domains of intelligence quotient (IQ), processing speed, working memory, executive functioning, learning ability, and visual-motor function, using linear mixed models. We explored associations with disease- and treatment-related factors and used multivariate normative comparison (MNC) to determine the prevalence of cognitive impairment. RESULTS: There were 21 PHIV+ and 23 HIV- participants that completed 2 assessments and were similar concerning age, sex, ethnicity, and SES. Compared to HIV- participants, in PHIV+ participants the IQ score increased significantly more over time (group*time 6.01, 95% confidence interval [CI] 1.5-10.50; P = .012), whereas executive functioning decreased significantly more (group*time -1.43 z score, 95% CI -2.12 to -0.75; P < .001), resulting in the disappearance and appearance of significant differences. Processing speed, working memory, learning ability, and visual-motor function trajectories were not statistically different between groups. Univariately, those who had started cART at an older age deviated more in executive functioning (-0.13 z score, 95% CI -0.24 to -0.02; P = .043). The prevalence of cognitive impairments by MNC was similar in both groups, at both time points. CONCLUSIONS: The cART-treated PHIV+ adolescents appeared to have similar global cognitive development, compared to their healthy peers. Executive functioning trajectory appears to deviate, potentially explained by earlier brain damage.
引用
- Van den Hof M, Ter Haar AM, Scherpbier HJ, et al. Neurocognitive Development in Perinatally Human Immunodeficiency Virus-infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal Study. Clin Infect Dis. 2020. PMID: 31106812. doi:10.1093/cid/ciz386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。